Risk factors for erosive esophagitis and Barrett's esophagus in a high Helicobacter pylori prevalence area

Medicina

Volumn 47, Issue 8, 2011, Pages 434-439

  Jonaitis, Laimas ^a   Kriukas, Darius ^b   Kiudelis, Gediminas ^a   Kupčinskas, Limas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b Republican Panevezys Hospital   (Lithuania)

Author keywords

Barrett's esophagus; Erosive esophagitis; Helicobacter pylori; Prevalence

Indexed keywords

EID: 84856658815     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina47080065     Document Type: Article

References (31)

1. Delaney BC. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004;20(Suppl 8):2-4.
2. Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004;53(8):1070-4.
3. Younes M, Henson DE, Ertan A, Miller CC. Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol 2002;37:1359-65.
4. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008;100:1184-7.
5. Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA 2002;287(15):1972-81.
6. Kulig M, Nocon M, Vieth M, Leodolter A, Jaspersen D, Labenz J, et al. Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 2004;57:580-9.
7. Miciulevičienė J, Calkauskas H, Jonaitis L, Kiudelis G, Tamošiūnas V, Praškevičius A, et al. Helicobacter pylori genotypes in Lithuanian patients with chronic gastritis and duodenal ulcer. Medicina (Kaunas) 2008;44:449-5.
8. Jonaitis L, Kupčinskas J, Kiudelis G, Kupčinskas L. De novo erosive esophagitis in duodenal ulcer patients related to preexisting reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study. Medicina (Kaunas) 2010;46:454-9.
9. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.
10. Sampliner RE. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. The practice parameters committee of the American College of Gastroenterology. Am J Gastroenterol 1998;93:1028-32.
11. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976;21:953-6.
12. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-7.
13. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US upper gastrointestinal study. Clin Gastroenterol Hepatol 2005;3:543-52.
14. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 2008;57:1354-9.
15. Flameling RD, Numans ME, Linde J, De Wit NJ, Siersema PD. Different characteristics of patients with gastro-oesophageal reflux disease on their path through healthcare: a population follow-up study. Eur J Gastroenterol Hepatol 2010;22:578-82.
16. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40:275-85.
17. Peng S, Cui Y, Xiao YL, Xiong LS, Hu PJ, Li CJ, et al. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. Endoscopy 2009;41:1011-7.
18. Sampliner RE. A population prevalence of Barrett's esophagus - finally. Gastroenterology 2005;129:2101-3.
19. Veldhuyzen van Zanten SJ, Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, et al. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Aliment Pharmacol Ther 2006;23: 595-9.
20. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:1670-7.
21. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825-31.
22. Wang FW, Tu MS, Chuang HY, Yu HC, Cheng LC, Hsu PI. Erosive esophagitis in asymptomatic subjects: risk factors. Dig Dis Sci 2010;55:1320-4.
23. Nocon M, Labenz J, Willicj SN. Lifestyle factors and symptoms of gastro-oesophageal reflux - a population-based study. Aliment Pharmacol Ther 2006;23:169-74.
24. Dore MP, Maragkoudakis E, Fraley K, Pedroni A, Tadeu V, Realdi G, et al. Diet, lifestyle and gender in gastro-oesophageal reflux disease. Dig Dis Sci 2008;53:2027-32.
25. Jonaitis L, Kiudelis G, Kupčinskas L. Characteristics of patients with erosive and nonerosive GERD in high-Helicobacter-pylori prevalence region. Dis Esophagus 2004;17: 223-7.
26. Campos GM, DeMeester SR, Peters JH, Oberg S, Crookes PF, Hagen JA, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg 2001;136:1267-73.
27. Gordon C, Kang JY, Neild PJ, Maxwell JD. The role of the hiatus hernia in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004;20:719-32.
28. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Risk factors for erosive reflux esophagitis: a case-control study. Am J Gastroenterol 2001;96:41-6.
29. Falkenback D, Oberg S, Johnsson F, Johansson J. Follow-up of a cohort of children and adolescents with gastro-esophageal reflux disease who were free of reflux esophagitis at initial diagnosis. Scand J Gastroenterol 2009;44:1277-87.
30. Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, Schnell J, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7.
31. Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, Perez-Perez GI, et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 2000;95:2206-11.